Endocrinology News

BOSTON — Among adults with COPD, the odds for exacerbations and hospitalizations were elevated in patients who did not use vs. did use the diabetes medication metformin, according to an abstract presented at the CHEST Annual Meeting.

Patients using testosterone replacement therapy for at least 3 months may have an increased risk for ACL injuries, according to recently published data.

Recent research has suggested that GLP-1 agonists used to treat obesity might be associated with a stroke in the optic nerve, but association is not the same as causation.

A paper recently published in JAMA Ophthalmology by Hathaway and colleagues at Harvard suggested a potential association between prescribed semaglutide and an increased risk for nonarteritic anterior ischemic optic neuropathy.

Drugs utilized to treat systemic diseases can do harm to the eye and its neural connections.

SAN ANTONIO — A swallowable hydrogel capsule that expands in the stomach demonstrated significant weight-loss, cardiovascular, glycemic and quality of life benefits for patients with overweight or obesity, a speaker reported.

SAN ANTONIO — In this Healio video exclusive from ObesityWeek, Fatima Cody Stanford, MD, MPH, MPA, MBA, MACP, FAAP, FAHA, FTOS, discusses equitable access to obesity care and treatments in the U.S.

SAN ANTONIO — When asked common questions regarding anti-obesity medications, GPT-4 responses were easy to interpret, accurate and comparable to responses provided by the FDA, according to findings presented at ObesityWeek.

SAN ANTONIO — Higher concentrations of some phthalate and plasticizer metabolites were associated with higher odds of metabolic syndrome in U.S. adolescents and young adults, according to an analysis presented at ObesityWeek.

According to published results, glucagon-like peptide-1 agonists may not be associated with increased complications for patients with diabetes who undergo total hip arthroplasty.